vs

Side-by-side financial comparison of Ardmore Shipping Corp (ASC) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $81.2M, roughly 1.0× Ardmore Shipping Corp). Ardmore Shipping Corp runs the higher net margin — 15.7% vs -38.1%, a 53.8% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -15.5%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs -6.0%).

Ardmore Shipping Corp is a global maritime transport company that owns and operates a fleet of mid-sized product and chemical tankers. It provides seaborne transport for petroleum products, specialty chemicals and bulk liquid commodities, serving energy, chemical and trading clients across key international trade routes.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

ASC vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.0× larger
PRCT
$83.1M
$81.2M
ASC
Growing faster (revenue YoY)
PRCT
PRCT
+35.7% gap
PRCT
20.2%
-15.5%
ASC
Higher net margin
ASC
ASC
53.8% more per $
ASC
15.7%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
-6.0%
ASC

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
ASC
ASC
PRCT
PRCT
Revenue
$81.2M
$83.1M
Net Profit
$12.8M
$-31.6M
Gross Margin
64.9%
Operating Margin
16.1%
-4.1%
Net Margin
15.7%
-38.1%
Revenue YoY
-15.5%
20.2%
Net Profit YoY
-47.0%
-27.9%
EPS (diluted)
$0.30
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASC
ASC
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$76.4M
Q3 25
$81.2M
$83.3M
Q2 25
$72.0M
$79.2M
Q1 25
$74.0M
$69.2M
Q4 24
$68.2M
Q3 24
$96.1M
$58.4M
Q2 24
$121.3M
$53.4M
Net Profit
ASC
ASC
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-29.8M
Q3 25
$12.8M
$-21.4M
Q2 25
$9.6M
$-19.6M
Q1 25
$6.3M
$-24.7M
Q4 24
$-18.9M
Q3 24
$24.1M
$-21.0M
Q2 24
$62.7M
$-25.6M
Gross Margin
ASC
ASC
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
ASC
ASC
PRCT
PRCT
Q1 26
-4.1%
Q4 25
-40.6%
Q3 25
16.1%
-27.8%
Q2 25
13.5%
-28.0%
Q1 25
8.6%
-39.7%
Q4 24
-28.9%
Q3 24
25.4%
-38.4%
Q2 24
51.3%
-50.3%
Net Margin
ASC
ASC
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-39.1%
Q3 25
15.7%
-25.7%
Q2 25
13.3%
-24.7%
Q1 25
8.5%
-35.8%
Q4 24
-27.6%
Q3 24
25.1%
-35.9%
Q2 24
51.7%
-48.0%
EPS (diluted)
ASC
ASC
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$-0.54
Q3 25
$0.30
$-0.38
Q2 25
$0.22
$-0.35
Q1 25
$0.14
$-0.45
Q4 24
$-0.34
Q3 24
$0.55
$-0.40
Q2 24
$1.47
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASC
ASC
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$245.6M
Total DebtLower is stronger
$116.1M
$51.7M
Stockholders' EquityBook value
$628.2M
$347.7M
Total Assets
$799.8M
$487.1M
Debt / EquityLower = less leverage
0.18×
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASC
ASC
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$286.5M
Q3 25
$294.3M
Q2 25
$302.7M
Q1 25
$316.2M
Q4 24
$333.7M
Q3 24
$196.8M
Q2 24
$214.1M
Total Debt
ASC
ASC
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$116.1M
$51.6M
Q2 25
$25.0M
$51.5M
Q1 25
$20.5M
$51.5M
Q4 24
$51.5M
Q3 24
$22.5M
$51.4M
Q2 24
$44.2M
$51.4M
Stockholders' Equity
ASC
ASC
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$365.9M
Q3 25
$628.2M
$380.3M
Q2 25
$618.3M
$385.8M
Q1 25
$610.7M
$389.2M
Q4 24
$402.2M
Q3 24
$627.0M
$241.2M
Q2 24
$617.7M
$251.8M
Total Assets
ASC
ASC
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$508.1M
Q3 25
$799.8M
$511.5M
Q2 25
$703.8M
$513.1M
Q1 25
$690.4M
$519.4M
Q4 24
$534.0M
Q3 24
$722.8M
$374.1M
Q2 24
$742.0M
$374.4M
Debt / Equity
ASC
ASC
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.18×
0.14×
Q2 25
0.04×
0.13×
Q1 25
0.03×
0.13×
Q4 24
0.13×
Q3 24
0.04×
0.21×
Q2 24
0.07×
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASC
ASC
PRCT
PRCT
Operating Cash FlowLast quarter
$17.9M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.40×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASC
ASC
PRCT
PRCT
Q1 26
Q4 25
$-10.3M
Q3 25
$17.9M
$-6.6M
Q2 25
$11.2M
$-15.0M
Q1 25
$26.3M
$-17.0M
Q4 24
$-32.4M
Q3 24
$39.9M
$-18.8M
Q2 24
$48.4M
$-15.7M
Free Cash Flow
ASC
ASC
PRCT
PRCT
Q1 26
Q4 25
$-12.2M
Q3 25
$-9.5M
Q2 25
$-17.8M
Q1 25
$-18.8M
Q4 24
$-33.6M
Q3 24
$-19.0M
Q2 24
$-16.8M
FCF Margin
ASC
ASC
PRCT
PRCT
Q1 26
Q4 25
-15.9%
Q3 25
-11.4%
Q2 25
-22.5%
Q1 25
-27.2%
Q4 24
-49.2%
Q3 24
-32.6%
Q2 24
-31.4%
Capex Intensity
ASC
ASC
PRCT
PRCT
Q1 26
Q4 25
2.4%
Q3 25
3.4%
Q2 25
3.5%
Q1 25
2.7%
Q4 24
1.7%
Q3 24
0.4%
Q2 24
2.0%
Cash Conversion
ASC
ASC
PRCT
PRCT
Q1 26
Q4 25
Q3 25
1.40×
Q2 25
1.17×
Q1 25
4.20×
Q4 24
Q3 24
1.65×
Q2 24
0.77×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASC
ASC

Segment breakdown not available.

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons